It leverages its innovative solutions to support T cell activation and expansion and includes a potent range of activating antibodies, cytokines, and expansion medium. Once activated, it is ...
Hosted on MSN12d
New research uncovers hidden rules of immune response, opening doors for better vaccines and immunotherapiesScientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells—the body's frontline ...
Genome-wide transcriptomics analysis of IFNγ-producing or IL-17A-producing γδ T cell subpopulations reveals marked differences in their mode of activation and functional potential in the periphery.
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...
6d
New Scientist on MSNCAR T-cells enable record-breaking 18-year nerve cancer remissionA person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...
AbbVie signs heavily backloaded $2.1B Xilio biobucks pact in Big Pharma's latest T-cell engager deal
Having kicked off the year with a T-cell engager deal, AbbVie has returned to the modality. | Having kicked off the year with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results